Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. by de Vries, F, Souverein, P, Cooper, C, Leufkens, H, van Staa, T

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose by De Vries, F, Souverein, P, Leufkens, H, Cooper, C, Van Staa, T

Use of alpha-blockers and the risk of hip/femur fractures. by Souverein, P, Van Staa, T, Egberts, A, De la Rosette, J, Cooper, C, Leufkens, H

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. by Pouwels, S, Lalmohamed, A, Souverein, P, Cooper, C, Veldt, B, Leufkens, H, de Boer, A, van Staa, T, de Vries, F

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. by Pouwels, S, Lalmohamed, A, Souverein, P, Cooper, C, Veldt, B, Leufkens, H, de Boer, A, van Staa, T, de Vries, F

Use of organic nitrates and the risk of hip fracture: a population-based case-control study. by Pouwels, S, Lalmohamed, A, van Staa, T, Cooper, C, Souverein, P, Leufkens, H, Rejnmark, L, de Boer, A, Vestergaard, P, de Vries, F